See inside every stock. Pro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI100.97▲ 1.51%
← 079160 page
XStocksXray
Market X-Ray report · 22 October 2026

CJ CGV (079160)

Korea Stock Exchange · Korea · prices in KRW · close of 22 Oct 2026

Key indicators

Last closeKRW 5,030.00
52-week range4,150.00 – 6,660.00
Return, 1 month / 3 months−4.0% / +14.4%
Return, 1 year / 3 years−1.6% / +3.4%
TrendBelow its 200-day average
RSI (14)46
Volatility (1 year)41.8%
Worst drawdown (1 year)-35.8%
Average daily value traded2,832.11M KRW
Dividend yield–

Market X-Ray price-based

75/ 100 · High confidence · ahead of 93% of stocks on this exchange
Trend80
Momentum79
Stability (higher is calmer)66
Liquidity71
Income–

Five-year price chart navy: price · brown: 200-day average

2,7909,46316,13522,80729,4802021-122023-012024-032025-072026-10

About the company

CJ CGV operates multiplex cinemas under the CGV brand, showing films to general audiences in theatres across Korea and in several overseas markets. The company runs its own cinema sites and provides the screens, seating and refreshment counters that go with them, and it also takes part in film distribution and related cinema services. It is based in Korea and belongs to the CJ group of companies.

CJ CGV trades under the code 079160 on the Korea Stock Exchange in Korea, with its price quoted in South Korean won (KRW). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

CJ CGV (079160) trades on the Korea Stock Exchange in Korea. It last closed at KRW 5,030.00 on 22 October 2026.

Its price-based Market X-Ray is 75 out of 100 (a strong price profile), ranking 62 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 1.6% and over the last three months it rose 14.4%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
CJ CGV (079160)

The five lenses in numbers each metric is ranked against the other stocks on Korea Stock Exchange

Lens and metricValueScoreReading
Trend80 · StrongTrading above its long-term averages and near its highs.
Above 200-day average-1.8%
From 52-week high-23.4%
Momentum79 · StrongRising faster than most stocks on this exchange.
3-month return14.4%
6-month return2.7%
12-month return, skipping the last month2.5%
Stability (higher is calmer)66 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)41.8%
Worst drawdown, 1 year (smaller is calmer)-35.8%
Liquidity71 · StrongTrades actively.
Average daily value traded2,832.11M KRW
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Trend: Trading above its long-term averages and near its highs.
  • Momentum: Rising faster than most stocks on this exchange.
  • Liquidity: Trades actively.

Weak spots

No lens is weak against its exchange.

Returns

1 week+2.7%
1 month−4.0%
3 months+14.4%
6 months+2.7%
1 year−1.6%
3 years+3.4%
5 years−76.5%

Signals

50-day / 200-day average5,248.10 / 5,120.63
Golden / death cross (60 days)Golden, 15 days ago
New 52-week highNo
Bullish RSI divergenceYes
Average daily range (ATR)166.43

Technical summary

DailyBearish3 bullish · 4 neutral · 9 bearish
WeeklyStrongly bearish2 bullish · 1 neutral · 9 bearish
MonthlyStrongly bearish1 bullish · 1 neutral · 6 bearish

Recent dividends

Ex-dividend dateAmount per share
27 Dec 2019KRW 222.9834

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 23 Oct 2026